Status:

UNKNOWN

DCB for Dialysis Access Stent Graft Restenosis

Lead Sponsor:

National Taiwan University Hospital Hsin-Chu Branch

Conditions:

Hemodialysis Access Failure (Disorder)

Stent-Graft Restenosis

Eligibility:

All Genders

20-90 years

Phase:

NA

Brief Summary

Recurrent stenosis in hemodialysis access graft (AVG) is difficult to treat. For recurrent stenosis in the anastomotic junction can be treated by stent graft to improve long-term patency. However, the...

Detailed Description

Prosthetic arteriovenous hemodialysis access graft (AVG) has high incidences of venous anastomotic stenosis and access failure. A stent graft can be used in AVG with recurrent venous anastomotic steno...

Eligibility Criteria

Inclusion

  • Age of 20 to 90 years on regular hemodialysis at least 3 months
  • Had stent graft implemented at dialysis vascular access
  • Angiographic evidence of stenosis within the stent graft or less than 2 cm from the stent graft edge
  • Clinical evidence of a hemodynamically significant stenosis or thrombosis
  • Patient is able to provide written informed consent

Exclusion

  • Elbow fracture or any disease involve the elbow joint that prohibits the flexion maneuver.
  • Target lesion cannot be crossed by the guide wire.
  • Known hypersensitivity to heparin or contrast medium.
  • Bleeding diathesis.
  • Patients participating in another clinical trial with interfering with this trial in the past three months.
  • Untreatable bleeding diathesis.
  • Other diseases, such as cancer, liver disease, or cardiac insufficiency, which may lead to protocol violations or markedly shorten a patient's life expectancy (less than 3 months).
  • Patients unable or unwilling to participate this trial.
  • Pregnancy, lactating woman, non-adult, criminals in sentence, psychiatric patients, research staffs or colleagues are prohibited.

Key Trial Info

Start Date :

March 5 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2019

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03360279

Start Date

March 5 2017

End Date

December 31 2019

Last Update

December 4 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital Hsinchu Branch

Hsinchu, Hsinchu City, Taiwan, 300